Skip to content

13F-HR filed by Tamarack Capital Management, LLC

Tamarack Capital Management, LLC filed this 13F-HR for the quarter ended 2013-06-30, filed 2013-08-09, with 24 holding rows worth $178,525,000.

Accession
0001095449-13-000082
Filed
2013-08-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2013

A holdings report, 24 entries on the cover page, a total value of $178,525,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $178,527,000 with VALUE read as thousands by filing date, 13F file number 028-15086. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GREATBATCH INC39153L106COM500,000$16,395,000thousands by filing date
PACIRA BIOSCIENCES INC COM695127100Stock548,900$15,918,000thousands by filing date
ALKERMES PLCG01767105SHS550,000$15,774,000thousands by filing date
MEDASSETS INC584045108COM581,094$10,309,000thousands by filing date
VIROPHARMA INC928241108COMMON STOCK325,000$9,311,000thousands by filing date
HAEMONETICS CORP MASS COM405024100Stock225,000$9,304,000thousands by filing date
ATRICURE INC04963C209COM872,447$8,288,000thousands by filing date
RTI BIOLOGICS INC74975N105COM2,161,868$8,129,000thousands by filing date
ALLERGAN INC018490102COM95,000$8,003,000thousands by filing date
DEXCOM INC COM252131107Stock350,000$7,858,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR200,000$7,840,000thousands by filing datecall
VARIAN MED SYS INC92220P105COM115,000$7,757,000thousands by filing date
SPECTRANETICS CORP84760C107COM399,627$7,465,000thousands by filing date
VOCERA COMMUNICATIONS INC92857F107COMMON STOCK472,105$6,940,000thousands by filing date
PERRIGO CO PLC F714290103COM55,000$6,655,000thousands by filing date
COVIDIEN PLCG2554F113SHS105,000$6,598,000thousands by filing date
LABORATORY CORP OF AMERICA50540R409COM NEW65,000$6,507,000thousands by filing date
VOLCANO CORPORATION928645100COM319,443$5,792,000thousands by filing date
SOLTA MED INC83438K103COM1,804,391$4,114,000thousands by filing date
BRUKER CORP116794108COM200,000$3,230,000thousands by filing date
STANDARD BIOTOOLS INC34385P108COM144,402$2,521,000thousands by filing date
NATUS MEDICAL INC639050103COM151,144$2,063,000thousands by filing date
GENTIVA HEALTH SERVICES37247A102COM134,547$1,340,000thousands by filing date
AUXILIUM PHARMACEUTICALS05334D107COMMON STOCK25,000$416,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001095449-13-000082this filing2013-08-09acceptance time not in the bulk data set